These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease. Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523 [TBL] [Abstract][Full Text] [Related]
5. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871 [TBL] [Abstract][Full Text] [Related]
6. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of cyclic AMP and iodide accumulation responses to thyroid-stimulating immunoglobulins in cultured FRTL-5 cells. Bidey SP; Ekins RP Clin Endocrinol (Oxf); 1986 Apr; 24(4):447-58. PubMed ID: 2874907 [TBL] [Abstract][Full Text] [Related]
8. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. Orgiazzi J; Williams DE; Chopra IJ; Solomon DH J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604 [TBL] [Abstract][Full Text] [Related]
9. Graves' immunoglobulin G stimulates iodothyronine 5'-deiodinating activity in FRTL-5 rat thyroid cells. Toyoda N; Nishikawa M; Horimoto M; Yoshikawa N; Mori Y; Yoshimura M; Masaki H; Tanaka K; Inada M J Clin Endocrinol Metab; 1990 Jun; 70(6):1506-11. PubMed ID: 1971826 [TBL] [Abstract][Full Text] [Related]
12. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)]. Abe Y Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
14. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay. Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497 [TBL] [Abstract][Full Text] [Related]
15. TSH binding by globulins from patients with Graves' disease. Bíró J Endocrinol Exp; 1981; 15(2):145-53. PubMed ID: 6114853 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of the binding of Graves' immunoglobulins by the patients own and other thyroid membranes. Gossage AA; Byfield PG; Copping S; Himsworth RL Clin Endocrinol (Oxf); 1981 Mar; 14(3):301-10. PubMed ID: 6894892 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins. Cho BY; Shong YK; Lee HK; Koh CS; Min HK Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181 [TBL] [Abstract][Full Text] [Related]
18. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393 [TBL] [Abstract][Full Text] [Related]
19. An investigation of the ability of TSH and Graves' immunoglobulin G to increase intracellular calcium in human thyroid cells, rat FRTL-5 thyroid cells and eukaryotic cells transfected with the human TSH receptor. MacNeil S; Munro DS; Metcalfe R; Cotterell S; Ruban L; Davies R; Weetman AP J Endocrinol; 1994 Dec; 143(3):527-40. PubMed ID: 7836899 [TBL] [Abstract][Full Text] [Related]
20. Untreated Graves' but not remission Graves' immunoglobulin G preparations increase intracellular Ca2+ in FRTL-5 thyroid cells. Kuwabara A; Okajima F; Akiyama H; Kobayashi I; Kondo Y Endocr J; 1996 Oct; 43(5):457-67. PubMed ID: 8980884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]